Extending venous thromboembolism secondary prevention with apixaban in cancer patients. The EVE trial.
McBane RD 2nd, Loprinzi CL, Zemla T, Tafur A, Sanfilippo K, Liu JJ, Garcia DA, Heun J, Gundabolu K, Onitilo AA, Perepu U, Drescher MR, Henkin S, Houghton D, Ashrani A, Billett H, McCue SA, Lee MK, Le-Rademacher JG, Wysokinski WE; EVE trial investigators.
McBane RD 2nd, et al. Among authors: mccue sa.
J Thromb Haemost. 2024 Jun;22(6):1704-1714. doi: 10.1016/j.jtha.2024.03.011. Epub 2024 Mar 25.
J Thromb Haemost. 2024.
PMID: 38537780
Clinical Trial.